-
Hamburg - seca, the leader in medically validated bioimpedance measuring devices for body composition analysis, is thrilled to announce the addition of Nik Elphick to the team as a Fitness Sales Manager. With his extensive background in the health and fitness industry, including remarkable achievements in project management, sales, and wellness program development, Nik brings just the right skills to propel our team forward, enhancing our capabilities in delivering our fitness and health revolution to the world of fitness.
-
In a resounding endorsement of its commitment to pioneering solutions, seca proudly secures the 35th position among Germany's most innovative companies, as per the esteemed SZ Institute of Süddeutsche Zeitung. Out of a comprehensive analysis of 2,575 companies, seca emerges as a lighthouse of innovation, firmly establishing itself in the upper levels of forward-thinking enterprises.
-
seca is pleased to announce the recognition of Sebastian Tils by the Hamburg Chamber of Commerce for his exceptional achievements in completing his apprenticeship. Alongside 73 other standout trainees, Sebastian showcased remarkable success in their final exams, scoring 91.5 out of 100 points or better – a noteworthy accomplishment among Hamburg's 13,000 apprentices.
-
At the end of a successful year, the signs are pointing to expansion at seca: the specialist for medically validated bioimpedance measuring devices for determining body composition is entering the up-and-coming fitness market in the BeNeLux countries.
-
In connection with the latest findings about Log4J vulnerabilities, seca has conducted extensive analyses to ensure the security of our devices and thus the (data) security of our customers.
The open source tool called Log4J is not used in any of our products. This means that none of our products are affected by the security vulnerabilities. In the development of our products we attach great importance to the highest security standards and will do our utmost to maintain them in the future, so that our partners can rely on us.
If you have any further questions, please contact info@seca.com.
-
The COVID-19 pandemic poses major challenges to doctors and health systems worldwide. People with pre-existing health conditions have an even higher risk of experiencing a severe infection. Publications in medical journals and by independent organizations indicate that the exact measurement of vital parameters can play a major role in the treatment of risk groups with COVID-19. Height, weight, and vital signs such as blood pressure, oxygen saturation, pulse, and temperature are relevant for the exact dosage of medications and ventilator settings. In addition, this information helps with disease diagnosis and follow-up control measures.
Supply of hospitals, emergency departments and medical practices has the highest priority
-
In many countries, authorities and competent institutions have classified seca and its medical technology as system relevant to support health systems in the fight against the COVID 19 pandemic. Due to the current situation, the pressure in emergency rooms and hospitals is very high and the need for medical technology has continued to increase. The company is maintaining production and expanding capacities to best serve this demand and to contribute to the fight against the corona virus.
-
While the whole world is attempting to slow down the number of new infections with coronavirus, we are concentrating on protecting our employees and instituting measures to make sure our production in Hamburg remains fully operational. Our production site in Hangzhou has returned to 90 percent of production capacity since China ended its shutdown. That gives us hope and sends a positive signal to everyone. We take this opportunity to thank all our employees and partners whose support and engagement are keeping our products and service available to all who need them.
